Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-03-25 | CUMBERLAND PHARMACEUTICALS INC | Krogulski Kenneth
(Director) |
A | Common Stock | A | 5000 | $1.71 - $1.71 | $8,550 |
| 2024-03-25 | CUMBERLAND PHARMACEUTICALS INC | Jones James
(Director) |
A | Common Stock | A | 1000 | $1.71 - $1.71 | $1,710 |
| 2024-03-25 | CUMBERLAND PHARMACEUTICALS INC | Galante Joseph C
(Director) |
A | Common Stock | A | 1000 | $1.71 - $1.71 | $1,710 |
| 2024-03-25 | CUMBERLAND PHARMACEUTICALS INC | Young Caroline
(Director) |
A | Common Stock | A | 1000 | $1.71 - $1.71 | $1,710 |
| 2024-03-25 | CUMBERLAND PHARMACEUTICALS INC | Brown Martin S JR
(Director) |
A | Common Stock | A | 1000 | $1.71 - $1.71 | $1,710 |
| 2024-03-23 | CUMBERLAND PHARMACEUTICALS INC | KAZIMI A J
(Chairman and CEO) |
F | Common Stock | D | 25710 | $1.81 - $1.81 | $46,535 |
| 2024-03-23 | CUMBERLAND PHARMACEUTICALS INC | Herman James L
(VP and Chief Compliance Office) |
F | Common Stock | D | 1186 | $1.81 - $1.81 | $2,146 |
| 2024-03-23 | CUMBERLAND PHARMACEUTICALS INC | Bitterman Chris T.
(Vice Pres Sales & Marketing) |
F | Common Stock | D | 593 | $1.81 - $1.81 | $1,073 |
| 2024-03-23 | CUMBERLAND PHARMACEUTICALS INC | Anthony Todd M.
(Vice Pres Organizational Dev) |
F | Common Stock | D | 816 | $1.81 - $1.81 | $1,476 |
| 2024-03-23 | CUMBERLAND PHARMACEUTICALS INC | Hamm John M.
(VP Chief Financial Officer) |
F | Common Stock | D | 445 | $1.81 - $1.81 | $805 |
| 2023-12-01 | CUMBERLAND PHARMACEUTICALS INC | Jones James
(Director) |
L | Common Stock | A | 1174 | $1.65 - $1.89 | $2,068 |
| 2023-11-01 | CUMBERLAND PHARMACEUTICALS INC | Young Caroline
(Director) |
L | Common Stock | A | 952 | $1.66 - $2.06 | $1,733 |
| 2023-11-27 | CUMBERLAND PHARMACEUTICALS INC | Hamm John M.
(Chief Financial Officer) |
F | Common Stock | D | 352 | $1.67 - $1.67 | $587 |
| 2023-10-02 | CUMBERLAND PHARMACEUTICALS INC | Young Caroline
(Director) |
L | Common Stock | A | 1148 | $1.79 - $2.24 | $2,291 |
| 2023-10-02 | CUMBERLAND PHARMACEUTICALS INC | Jones James
(Director) |
L | Common Stock | A | 1148 | $1.79 - $2.24 | $2,291 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |